Spherix Global Insights Announces Special Coverage of Amgen’s Amjevita Launch, Tracking Uptake and Perceptions of the First Commercially-available Biosimilar to AbbVie’s Humira
According to a survey of autoimmune specialists, in the first week of launch, aided awareness of Amjevita is high, but